BR Shuman, M Goudriaan, L Bar-On, MH Schwartz, K Desloovere, KM Steele (2016) “Repeatability of muscle synergies within and between days for typically developing children and children with cerebral palsy.” Gait & Posture.

BR Shuman, M Goudriaan, L Bar-On, MH Schwartz, K Desloovere, KM Steele (2016) “Repeatability of muscle synergies within and between days for typically developing children and children with cerebral palsy.” Gait & Posture.

Journal article in Gait and Posture:

Filtering parameters impact the results from muscle synergy analyses.

Top: Average tVAF for day 1 and day 2 in TD and CP calculated from all measured gait cycles. The LME model identified a significant difference in synergy complexity between TD and CP for n = 1–5 synergies. Bottom: Average tVAF for each of the three walking speeds in TD and CP from both days. Walking speed had a significant effect on synergy complexity for tVAF of 1–5 synergiesAbstract: Muscle synergies are typically calculated from electromyographic (EMG) signals using nonnegative matrix factorization. Synergies identify weighted groups of muscles that are commonly activated together during a task, such as walking. Synergy analysis has become an emerging tool to evaluate neuromuscular control; however, the repeatability of synergies between trials and days has not been evaluated. The goal of this study was to evaluate the repeatability of synergy complexity and structure in unimpaired individuals and individuals with cerebral palsy (CP). EMG data were collected from eight lower-limb muscles during gait for six typically developing (TD) children and five children with CP on two separate days, over three walking speeds. To evaluate synergy complexity, we calculated the total variance accounted for by one synergy (tVAF1). On a given day, the average range in tVAF1 between gait cycles was 18.2% for TD and 19.1% for CP. The average standard deviation in tVAF1 between gait cycles was 4.9% for TD and 5.0% for CP. Average tVAF1 calculated across gait cycles was not significantly different between days for TD or CP participants. Comparing synergy structure, the average (standard deviation) within day correlation coefficients of synergy weights for two or more synergies were 0.89 (0.15) for TD and 0.88 (0.15) for CP. Between days, the average correlation coefficient of synergy weights for two or more synergies was greater than 0.89 for TD and 0.74 for CP. These results demonstrate that synergy complexity and structure averaged over multiple gait cycles are repeatable between days in both TD and CP groups.

Two NIH R01 Grants Funded

NIH logoThe Ability & Innovation Lab is excited to announce that two of our recent grant proposals have been funded! This funding will help to accelerate our mission to improve movement for individuals with neurologic disorders.

Quantifying patient-specific changes in neuromuscular control in cerebral palsyFunded by the National Institute of Neurological Disorders and Stroke, this research will examine how new measures of neuromuscular control can be used to better predict outcomes after multi-level orthopaedic surgery for individuals with cerebral palsy. We will be working in close partnership with Gillette Children’s Specialty Healthcare, one of the leading institutions in the management of pediatric neurological disorders. This research will address the challenge of identifying the best treatment for each individual. Cerebral palsy is caused by a brain injury and every brain injury is unique. We will be using new measures from muscle synergy analysis (see prior work here) to determine how patient-specific measures of control can be used to predict outcomes after surgery.

Ubiquitous rehabilitation to improve movement after neurologic injury: Funded by the joint NSF-NIH Smart & Connected Health Initiative, this research will work in partnership with the University of Texas at Austin to use flexible electrodes to track and train muscle activity after stroke and other neurologic injuries. We know that more practice and use after brain injury increases long-term recovery and function. This research will investigate new pathways for both motivating patients to re-learn to use their muscle and providing doctors and therapists with the data and insight needed to guide and customize therapy.